BridgeMD
Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients.
EU CTIS ID: 2025-521362-10-00
What this study is testing
The primary aim of this study is to evaluate the efficacy of a Single Measurement and adjustment strategy based on DOAC levels in the frail older population on the incidence of complications, in particular thromboembolic events or bleedings as composite outcome.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- In order to be eligible to participate in this study, a subject must meet all of the following criteria: (a) aged > 70 years; (b) using a DOAC (preferably among new users, defined as participants initiating treatment with a DOAC), (c) CFS > 3, (d) able to attend to the outpatient clinic (only applicable to community dwelling patients), and (e) able to provide informed consent.
You likely can't join if
- A potential subject who meets any of the following criteria will be excluded from participation in this study: (1) a life expectancy < 3 months, (2) not able to provide informed consent.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.